CORC

在结果中检索

CORC

浏览/检索结果: 共484条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
An electrochemical molecularly imprinted microfluidic paper-based chip for detection of inflammatory biomarkers IL-6 and PCT 期刊论文
ANALYST, 2023, 页码: 9
作者:  Li, Wenpeng;  Xiang, Jiawen;  Han, Jinglong;  Man, Mingsan;  Chen, Lingxin
收藏  |  浏览/下载：1/0  |  提交时间：2024/01/26
Genome-Wide Identification of Aqp Family Related to Spermatogenesis in Turbot (Scophthalmus maximus) 期刊论文
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 卷号: 24, 期号: 14, 页码: 12
作者:  Wang, Xueying;  Zhao, Ning;  Wang, Tao;  Huang, Jinwei;  Liu, Qinghua
收藏  |  浏览/下载：4/0  |  提交时间：2023/12/13
PD-L1 Aptamer-Functionalized Metal-Organic Framework Nanoparticles for Robust Photo-Immunotherapy against Cancer with Enhanced Safety 期刊论文
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 页码: 9
作者:  Zhang, Jingfang;  Li, Wenzhe;  Qi, Yafei;  Wang, Guorong;  Li, Lele
收藏  |  浏览/下载：14/0  |  提交时间：2023/02/22
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi
收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文
BMC Medicine, 2022, 卷号: 20, 期号: 1
作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun
收藏  |  浏览/下载：123/0  |  提交时间：2022/11/21
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文
BRITISH JOURNAL OF CANCER, 2022
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
收藏  |  浏览/下载：21/0  |  提交时间：2022/12/22
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载：17/0  |  提交时间：2022/12/22
A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Wang, Jing;  Lou, Hanmei;  Cai, Hong-Bing;  Huang, Xin;  Li, Guiling
收藏  |  浏览/下载：17/0  |  提交时间：2022/12/23
Label-Free Detection and Translocation Dynamics Study of Single-Molecule Herceptin Using Solid-State Nanopores 期刊论文
ADVANCED MATERIALS TECHNOLOGIES, 2022
作者:  Hu, Rui;  Lu, Wenlong;  Wei, Guanghao;  Nan, Hexin;  Li, Juan
收藏  |  浏览/下载：10/0  |  提交时间：2022/12/23
Tisotumab vedotin for the treatment of cervical carcinoma 期刊论文
DRUGS OF TODAY, 2022, 卷号: 58, 期号: 5, 页码: 213-222
作者:  Song, Xin;  Li, Ruyi;  Wang, Hongwei;  Song, Peng;  Guo, Wenjing
收藏  |  浏览/下载：22/0  |  提交时间：2022/06/21

©版权所有 ©2017 CSpace - Powered by CSpace